Notas del episodio
In this episode, we sit down with Anthony Noble , who serves as the CEO and Managing Director of The Calmer Co (ASX:CCO). Join us as we delve into the most recent developments and valuable insights within CCO, and take a closer look at what drives Anthony's success.
Formerly, C.E.O. Australian Biotherapeutics, and spent more than 10 years at Soho Flordis International (SFI) which includes Klaire Labs, Prothera & Complementary Prescriptions (USA), Ginsana SA (Switzerland), Flordis (Australia) and Potters Herbals & Equazen (UK). Anthony held the roles of Global Head of Innovation, Global Head of B2B, Head of North Asia and Managing Director of SFI Research Pty Ltd, the group’s innovation incubator and investment company. Anthony has a PhD in Cell Biology and an MBA from AGSM including study at the Wharton School (U Penn)